NYRx Formulary Update: Nucynta and Xtampza No Longer Covered Click to Enlarge Effective January 1, 2025, Collegium Pharmaceutical, the manufacturer of Nucynta®, Nucynta ER®, and Xtampza® is no longer participating in the Medicaid Drug Rebate Program and therefore these drugs will no longer be covered by NYRx.
Statement from MSSNY President Jerome C. Cohen, MD Click to Enlarge "We appreciate Governor Hochul's focus in her State of the State message on expanding the ability of New Yorkers to receive needed care, including enhancing outdated health plan network adequacy standards that often cause limited care
Women Physicians Leadership Academy Spring Sessions Click to Enlarge Registration is now open for MSSNY’s MESF Women Physicians Leadership Academy! Dr. Tochi Iroku-Malize will lead three virtual sessions on Saturday, February 1st, Sunday, March 2nd, and Saturday, March 15th, from 7:45 a.m. to 11:15 a.m. These sessions
Capital Update: Volume 35, No. 1, January 17, 2025 Click to Enlarge Statement of MSSNY President Dr. Jerome Cohen, MD, in reaction to Governor Hochul’s State of the State Message MSSNY Voices Both Optimism and Concern Over Governor’s State of the State Message Please Plan to
Physicians Outraged at Congress’s Inaction on Medicare: MSSNY Urges Congress to Fix Payment Cuts to Physicians Early in 2025 Click to Enlarge MSSNY is continuing to work closely with the American Medical Association (AMA) and other physician advocacy groups to urge Congress to stop the 2.8%
5 Key Healthcare Topics for 2025 (and Why You Should Care) Click to Enlarge As the healthcare industry enters 2025, several critical topics are set to redefine care delivery and organizational strategies, presenting both challenges and opportunities. Experts emphasize that understanding these trends will be pivotal for
Practice Landscape: Challenges and Needs in a Time of Practice Acquisition/Consolidation Click to Enlarge The Medical Society of the State of New York, in coordination with the American Medical Association, is asking physicians to answer a survey to help inform our advocacy and legislative efforts. We
